FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

REGISTER

now for free

AJ MacLellan

Research Profile

Chemicals & Drugs

Procedures

Living Beings

Disorders

Genes & Molecular Sequences

Amino Acid Sequences

Concepts & Ideas

Anatomy

Register to see full profile

Co-author Network

Register to see all co-authors

Publications

TOP 3
S Clive; D J Webb; AJ MacLellan; A Young; B Byrne; L Robson; John F Smyth; Duncan I Jodrell
Forearm blood flow and local responses to peptide vasodilators: a novel pharmacodynamic measure in the phase I trial of antagonist G, a neuropeptide growth factor antagonist.
Jeff Cummings; AJ MacLellan; M Mark; D I Jodrell
Development of a gradient elution high-performance liquid chromatography assay with ultraviolet detection for the determination in plasma of the anticancer peptide [Arg6, D-Trp7,9, mePhe8]-substance P (6-11) (antagonist G), its major metabolites and a C-terminal pyrene-labelled conjugate.
Duncan I Jodrell; Angela Bowman; Moira Stewart; N Dunlop; R French; AJ MacLellan; Jeff Cummings; John F Smyth
Dose-limiting neurotoxicity in a phase I study of penclomedine (NSC 388720, CRC 88-04), a synthetic alpha-picoline derivative, administered intravenously.

Register to see all publications

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Register to see more

Geonetwork of AJ MacLellan (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Register to see more

All Publications

2001: S Clive; D J Webb; AJ MacLellan; A Young; B Byrne; L Robson; John F Smyth; Duncan I Jodrell
Forearm blood flow and local responses to peptide vasodilators: a novel pharmacodynamic measure in the phase I trial of antagonist G, a neuropeptide growth factor antagonist.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(10):3071-8.
1999: Jeff Cummings; AJ MacLellan; M Mark; D I Jodrell
Development of a gradient elution high-performance liquid chromatography assay with ultraviolet detection for the determination in plasma of the anticancer peptide [Arg6, D-Trp7,9, mePhe8]-substance P (6-11) (antagonist G), its major metabolites and a C-terminal pyrene-labelled conjugate.
Journal of chromatography. B, Biomedical sciences and applications 1999;732(2):277-85.
1998: Duncan I Jodrell; Angela Bowman; Moira Stewart; N Dunlop; R French; AJ MacLellan; Jeff Cummings; John F Smyth
Dose-limiting neurotoxicity in a phase I study of penclomedine (NSC 388720, CRC 88-04), a synthetic alpha-picoline derivative, administered intravenously.
British journal of cancer 1998;77(5):808-11.
1998: GP Malcolm; D I Jodrell; AJ MacLellan; Gopal R Swaroop; Paul A T Kelly; Ian R Whittle
Effects of nitric oxide manipulation on the disposition of platinum in an experimental glioma model.
Neuroreport 1998;9(2):181-5.
1997: D A Jones; AJ MacLellan; Jeff Cummings; AA Ritchie; Simon P Langdon; John F Smyth
Processing of [D-Arg1,D-Phe5,D-Trp7,9,Leu11]substance P in xenograft bearing Nu/Nu mice.
Peptides 1997;18(7):1073-7.
1996: D A Jones; Jeff Cummings; Simon P Langdon; AJ MacLellan; T Higgins; E Rozengurt; John F Smyth
Metabolism of the broad-spectrum neuropeptide growth factor antagonist: [D-Arg1, D-Phe5, D-Trp7,9, Leu11]-substance P.
British journal of cancer 1996;73(6):715-20.
1995: D A Jones; Jeff Cummings; Simon P Langdon; AJ MacLellan; John F Smyth
Characterization of the deamidase enzyme responsible for the metabolism of the anticancer peptide: H-Arg-D-Trp-NmePhe-D-Trp-Leu-Met-NH2.
Biochemical pharmacology 1995;50(5):585-90.
1995: Jeff Cummings; AJ MacLellan; D A Jones; Simon P Langdon; E Rozengurt; AA Ritchie; John F Smyth
Pharmacokinetics, metabolism, tissue and tumour distribution of the neuropeptide growth factor antagonist [Arg6, D-Trp7,9, NmePhe8]- substance P(6-11) in nude mice bearing the H69 small-cell lung cancer xenograft.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1995;6(6):595-602.
1995: Jeff Cummings; AJ MacLellan; Simon P Langdon; D A Jones; E Rozengurt; John F Smyth
Processing of the neuropeptide growth factor antagonist [Arg6, D-Trp7.9, NmePhe8]-substance P (6-11) by a small cell lung cancer cell line (H69).
Biochemical pharmacology 1995;49(11):1709-12.
1995: D A Jones; Jeff Cummings; Simon P Langdon; AJ MacLellan; T Higgins; E Rozengurt; John F Smyth
Metabolism of the anticancer peptide H-Arg-D-Trp-NmePhe-D-Trp-Leu-Met-NH2.
Peptides 1995;16(5):777-83.
1994: Jeff Cummings; AJ MacLellan; Simon P Langdon; John F Smyth
Stability and in vitro metabolism of the mitogenic neuropeptide antagonists [D-Arg1,D-Phe5, D-Trp7,9, Leu11]-substance P and [Arg6, D-Trp7,9, MePhe8]-substance P (6-11) characterized by high-performance liquid chromatography.
Journal of pharmaceutical and biomedical analysis 1994;12(6):811-9.
1994: Jeff Cummings; AJ MacLellan; Simon P Langdon; E Rozengurt; John F Smyth
Determination of two neuropeptide growth factor antagonists, [D-Arg1,D-Phe5,D-Trp7,9,Leu11]-substance P and [Arg6,D-Trp7,9,N-MePhe8]- substance P(6-11), by high-performance liquid chromatography with electrochemical detection.
Journal of chromatography. B, Biomedical applications 1994;653(2):195-203.
1993: R C French; Jeff Cummings; AJ MacLellan; J S MacPherson; AA Ritchie; John F Smyth
The comparative disposition of the pyrolloquinone GR63178A and its 9-hydroxy metabolite GR54374X in sensitive and resistant mouse colon adenocarcinoma.
Cancer chemotherapy and pharmacology 1993;32(2):156-61.
1993: Jeff Cummings; AJ MacLellan; S J Langdon; John F Smyth
The long term stability of mechlorethamine hydrochloride (nitrogen mustard) ointment measured by HPLC.
The Journal of pharmacy and pharmacology 1993;45(1):6-9.
1991: Jeff Cummings; AJ MacLellan; John F Smyth; P B Farmer
Determination of reactive nitrogen mustard anticancer drugs in plasma by high-performance liquid chromatography using derivatization.
Analytical chemistry 1991;63(15):1514-9.
1991: Jeff Cummings; R C French; AJ MacLellan; John F Smyth
Chromatographic characterisation of six human metabolites of the new anticancer drug GR63178A.
Cancer chemotherapy and pharmacology 1991;28(1):27-32.

Register to see more

Copyright © 2011 Elsevier Inc. All rights reserved.